Erlotinib - Generic Drug Details
✉ Email this page to a colleague
US Patents and Regulatory Information for erlotinib
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apotex | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 208396-001 | Nov 5, 2019 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Hetero Labs Ltd V | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 209267-001 | May 24, 2024 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Msn | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 214366-001 | May 10, 2021 | AB | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |